Abstract:Abstract Glioma is an extremely aggressive malignant neoplasm of the central nervous system. MicroRNA (miRNA) are known to bind to specific target mRNA to regulate post-transcriptional gene expression and are, therefore, currently regarded as promising biomarkers for glioma diagnosis and prognosis. The aim of the present study was to examine the pathogenesis and potential molecular markers of glioma by comparing the differential expression of miRNA and mRNA between glioma tissue and peritumor brain tissue. We explored the impact of screened core miRNA and mRNA on cell proliferation, invasion, and migration of glioma. An miRNA expression profile dataset (GSE90603) and a transcriptome profile dataset (GSE90598) were downloaded from combined miRNA-mRNA microarray chips in the Gene Expression Omnibus (GEO) database. Overall, 59 differentially expressed miRNAs (DEMs) and 419 differentially expressed genes (DEGs) were identified using the R limma software package. FunRich software was used to predict DEM target genes and miRNA-gene pairs, and Perl software was used to find overlapping genes between DEGs and DEM target genes. There were 129 overlapping genes regulated by nine miRNAs between target genes of the DEMs and DEGs. The Chinese Glioma Genome Atlas(CGGA) was analyzed in order to identify miRNAs with diagnostic and prognostic significance. MiR-139-5p, miR-137, and miR-338-3p were validated to be significantly linked to prognosis in glioma patients. Finally, we validated that miR-139-5p affected glioma malignant biological behavior via targeting gamma-aminobutyric acid A receptor alpha 1(GABRA1) through rescue experiments. Low miR-139-5p expression was correlated with survival probability and World Health Organization (WHO) grade. MiR-139-5p overexpression inhibited cell proliferation, migration, and invasion of glioma in vitro. GABRA1 was identified as a functional downstream target of miR-139-5p. Decreased GABRA1 expression was related to similar biological roles as miR-139-5p overexpression while upregulation of GABRA1 effectively reversed the inhibition effects of miR-139-5p. These results demonstrate a novel axis for miR-139-5p/GABRA1 in glioma progression and provide potential prognostic predictors and therapeutic target for glioma patients.

Mir-27a Regulates Wnt/Beta-Catenin Signaling Through Targeting Sfrp1 in Glioma

A Predicted Mir-27A-mediated Network Identifies a Signature of Glioma.

miR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinase.

Mir-138-5p Suppresses Glioblastoma Cell Viability and Leads to Cell Cycle Arrest by Targeting Cyclin D3.

Emerging Role of Microrna-27a in Human Malignant Glioma Cell Survival Via Targeting of Prohibitin

MiR-27a Facilitates Breast Cancer Progression Via GSK-3β

Microrna-301a/Znrf3/Wnt/Beta-Catenin Signal Regulatory Crosstalk Mediates Glioma Progression

Mir-497/Wnt3a/C-Jun Feedback Loop Regulates Growth And Epithelial-To-Mesenchymal Transition Phenotype In Glioma Cells

CBMT-46. MICRORNA-206 ATTENUATES GLIOMA CELL PROLIFERATION, MIGRATION, AND INVASION BY BLOCKING THE WNT/β-CATENIN PATHWAY VIA DIRECT TARGETING OF FRIZZLED 7

MiR-27a-3p Targeting GSK3β Promotes Triple-Negative Breast Cancer Proliferation and Migration Through Wnt/β-Catenin Pathway

Mirna-27B Targets Vascular Endothelial Growth Factor C to Inhibit Tumor Progression and Angiogenesis in Colorectal Cancer

Mir-27A-3p Regulates Proliferation and Apoptosis of Colon Cancer Cells by Potentially Targeting BTG1

MiR-30a-5p is induced by Wnt/β-catenin pathway and promotes glioma cell invasion by repressing NCAM

MicroRNA-509-3p Inhibits Cell Proliferation and Invasion Via Downregulation of X-linked Inhibitor of Apoptosis in Glioma.

Promising Therapeutic Role of Mir-27B in Tumor

Upregulated Mir-27A-3p Indicates a Poor Prognosis in Pancreatic Carcinoma Patients and Promotes the Angiogenesis and Migration by Epigenetic Silencing of GATA6 and Activating VEGFA/VEGFR2 Signaling Pathway.

MiR-27a inhibits the growth and metastasis of multiple myeloma through regulating Th17/Treg balance

Mir-27a-3p Targeting Rxr Alpha Promotes Colorectal Cancer Progression By Activating Wnt/Beta-Catenin Pathway

Mir-139-5p inhibits glioma cell proliferation and progression by targeting GABRA1

Mir-24-3 P and Mir-27 A-3 P Promote Cell Proliferation in Glioma Cells Via Cooperative Regulation of MXI 1

Mir-137 Acts As a Tumor Suppressor in Astrocytoma by Targeting RASGRF1.